Researchers from Fifth Affiliated Hospital of Wenzhou Medical University Publish Findings in Personalized Medicine (Glycerophospholipid-driven lipid metabolic reprogramming as a common key mechanism in the progression of human primary...).

Researchers from the Fifth Affiliated Hospital of Wenzhou Medical University have published a study in personalized medicine focusing on the role of glycerophospholipid-driven lipid metabolic reprogramming in the progression of primary liver cancers such as hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA). The study utilized advanced metabolomics analysis to identify significant upregulation of lipid metabolites in patients with HCC and CCA, highlighting the potential of lipid metabolism as a therapeutic target. The findings offer new insights into addressing clinical challenges associated with these cancers, paving the way for early diagnosis and personalized treatment strategies for patients. [Extracted from the article]